p53 gene aberrations in non-small cell lung carcinomas from a smoking population

British Journal of Cancer

Volumn 75, Issue 8, 1997, Pages 1119-1124

  Liloglou, T ^a   Ross, H ^a   Prime, W ^a   Donnelly, R J ^b   Spandidos, D A ^c   Gosney, J R ^a   Field, J K ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^c INSTITUTE OF BIOLOGY   (Greece)

Author keywords

CpG dinucleotides; GC AT transition; Immunohistochemistry; Loss of heterozygosity; Lung tumours; Non small cell lung carcinoma; p53 expression; p53 mutations; Smokers

Indexed keywords

PROTEIN P53;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER GENETICS; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MALE; MUTATION RATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 0030941043     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.193     Document Type: Article

References (36)

1. Slamon D, Gazdar A and Minna J (1994) p53 immunostaining positively is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer. A preliminary report of LCSG 871. Chest 106: 377s-381S
2. Chiba I, Takahashi T and Nau MM (1990) Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 5: 1603-1610
3. DeMarini DM (1983) Genotoxicity of tobacco-smoke and tobacco-smoke condensate. Mutat Res 114: 59-89
4. DeMarini DM, Shelton ML and Levine LG (1995) Mutation spectrum of cigarette smoke condensate in Salmonella: comparison to mutations in smoking-associated tumours. Carcinogenesis 16: 2535-2542
5. Field JK, Stocker CJ, Neville EN and Taylor LA (1994) Molecular mechanisms in lung cancer. In International Congress for Lung Cancer. Antypas G (ed.), pp. 29-34. Monduzzi Editor International Proceedings Division: Bologna
6. Field JK, Kiaris H, Risk JM, Tsiriyotis C, Adamson R, Zoumpourlis V, Rowley H, Taylor K, Whittaker J, Howard P, Beirne JC, Gosney JR, Woolger J, Vaughan ED, Spandidos DA and Jones AS (1995) Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival. Br J Cancer 72: 1180-1188
7. Field JK, Neville EM, Stewart MP, Swift A, Liloglou T, Risk JM, Ross H, Gosney JR and Donnelly RJ (1996) Fractional allele loss data indicate distinct genetic populations in the development of non-small cell lung cancer. Br J Cancer 74: 1968-1974
8. Greenblatt MS, Bennett WP, Hollstein M and Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878
9. Hollstein M, Sidransky D, Vogelstein B and Harris CC (1991) p53 mutations in human cancers. Science 253: 49-53
10. Hollstein M, Rice K, Soussi T, Fuchs R, Sorlie T, Hivig E, Smithsorenson B, Montesano R and Harris CC (1994) Database of p53 gene somatic mutations in human tumours and cell lines. Nucl Acids Res 22: 3551-3555
11. Husgafvel-Pursiainen K, Ridanpaa M, Anttila S and Vainio H (1995) p53 and ras gene mutations in lung cancer: implications for smoking and occupational exposures. J Occup Environ Med 37: 69-76
12. Lane DP (1992) p53. guardian of the genome. Nature 358: 15-16
13. Lee LN, Shew JY, Sheu JC, Lee YC, Lee WC, Fang MT, Chang HF, Yu CJ, Yang PC and Luh KT (1994) Exon-8 mutation of p53 gene associated with nodal metastasis in non-small cell lung cancer. Am J Respir Crit Care Med 150: 1667-1671
14. Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV, Ullrich S, Romano JW, Appella E, Testa JR, Gerwin BI and Harris CC (1991) p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res 51: 4090-4096
15. Levine AJ, Momand J and Finlay CA (1991) The p53 tumour suppressor gene. Nature 351: 453-456
16. Lohmann D, Putz B, Reich U, Bohm J, Prauer H and Hofler H (1993) Mutational spectrum of the p53 gene in human small-cell lung cancer and relationship to clinicopathological data. Am J Pathol 142: 907-915
17. Mitsudomi T, Steinberg SM, Nau MM, Carbone D, Damico D, Bodner S, Oie HK, Linnoila RI, Mulshine JL, Minna JD and Gazdar AF (1992) p53 gene-mutations in non-small-cell-lung-cancer cell-lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7: 171-180
18. Mitsudomi T, Oyama T, Kusano T, Osaki T, Nakanishi R and Shirakusa T (1993) Mutations of the p53 gene as a predictor of poor prognosis in patients with non small cell lung cancer. J Natl Cancer Inst 85: 2018-2023
19. Neville EM, Ellison G, Kiaris H, Stewart MP, Spandidos DA, Fox JC and Field JK (1995a) Detection of K-ras mutations in non-small cell lung carcinoma. Int J Oncol 7: 511-514
20. Neville EM, Stewart MP, Myskow M, Donnelly RJ and Field JK (1995b) Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer. Oncogene 11:581-585
21. Neville EM, Stewart MP, Swift A, Risk JM, Liloglou T, Ross H, Gosney JR, Donnelly RJ and Field JK (1996) Allelotype of non-small cell lung cancer. Int J Oncol 9: 533-539
22. Ramet M, Castren K, Jarvinsen K, Pekkala K, Turpeenniemi-Hujanen T, Soini Y, Paakko P and Vahakangas K (1995) p53 protein expression correlated with henzoapyrenc-DNA adducts in carcinoma cell lines. Carcinogenesis 16: 2117-2124
23. Sameshima Y, Matsuno Y, Hirohashi S, Shimosato Y, Mizoguchi H, Sugimura T, Terada M and Yokota J (1992) Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene 7: 451-457
24. Shopland DR, Eyre HJ and Pechacek TF (1991) Smoking-attributable cancer mortality in 1991: is lung cancer the leading cause of death among smokers in the United States? J Natl Cancer Inst 83: 1142-1148
25. Sidransky D and Hollstein M (1996) Clinical implications of the p53 gene. Ann Rev Med 47: 285-301
26. Suzuki H, Takahashi T, Kuroishi T, Suyama M, Ariyoshi Y, Takahashi T and Ueda R (1992) p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res 52: 734-736
27. Takeshima Y, Seyama T, Bennett WP, Akiyama M, Tokuoka S, Inai K, Mabuchi K, Land CE and Harris CC (1993) p53 mutations in lung cancers from nonsmoking atomic bomb survivors. Lancet 342: 15211-1521
28. Tasheva ES and Roufa DJ (1994) Densely methylated DNA islands in mammalian chromosomal replication origins. Mol Cell Biol 14: 5636-5644
29. Westra ES, Offerhaus GJA, Goodman SN, Slebos RJC, Polak M, Baas IO, Rodenhuis S and Hruban RH (1993) Overexpression of the p53-tumour-supressor gene-product in primary lung adenocarcinomas is associated with cigarette smoking. Am J Surg Pathol 17: 213-220
30. Whitehouse JMA (1994) Management of Lung Cancer Current Clinical Practices 1994, Vol. I, pp. 1-55. Department of Health: London
31. Williams EMI, Youngson J, Ashby D and Donelly RJ (1992) Lung cancer bulletin - A framework for action. Merseyside and Cheshire Cancer Registry: Liverpool
32. Wynder EL and Hoffmann D (1994) Smoking and lung cancer: scientific challenges and opportunities. Cancer Res 54: 5284-5295
33. Yang AS, Gonzalgo ML, Zingg J-M, Millar RP, Buckley JD and Jones PA (1996) The rate of CpG mutations in Alu repetitive elements within the p53 tumour suppressor gene in the primate germline. J Mol Riol 258: 240-250
34. Yin YX, Tainsky MA, Bischoff FZ and Strong LC (1992) Wild-type p53 restores cell-cycle control and inhibils gene amplification in cells with mutant p53 alleles. Cell 70: 937-948
35. Youngson J and Williams EMI (1995 ) Incidence of lung cancer in Merseyside and Cheshire (1989-1993), Merseyside and Cheshire Cancer Registry: Liverpool
36. Zheng J, Shu QP, Li ZH, Tsao JL, Weiss LM and Shibata D (1994) Patterns of p53 mutations in squamous-cell carcinoma of the lung acquisition at a relatively early age. Am J Pathol 145: 1444-1449